Anna Ignatova

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology(Current)

Anna Ignatova is an author at Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology specializing in medicine, hematology, and immunology.

ORCID

Top concepts

MedicinePathologyHematologyImmunologyPediatricsImmunotherapyPathogenesisPrimary CareHistopathologyPatient Safety

Publications per year

2021–2023

Publications

Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA

D. A. Evseev, D. S. Osipova, Anna Ignatova et al. · International Journal of Hematology · 2021 · 27 citations

Pediatric Hematology, Medicine, Pathogenesis +12

Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH

D. A. Evseev, D. S. Osipova, Anna Ignatova et al. · Blood Advances · 2023 · 24 citations · Full text

Hematological Malignancy, Translational Medicine, Vemurafenib Cessation +14

Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine

Marta Salek, Alexandra S. Mueller, Inna Alanbousi et al. · The Lancet Oncology · 2023 · 12 citations

Blood Disorders, Family Medicine, Primary Care +8

1–3 of 3